259 related articles for article (PubMed ID: 30305427)
1. Lipocalin-Like Prostaglandin D Synthase but Not Hemopoietic Prostaglandin D Synthase Deletion Causes Hypertension and Accelerates Thrombogenesis in Mice.
Song WL; Ricciotti E; Liang X; Grosser T; Grant GR; FitzGerald GA
J Pharmacol Exp Ther; 2018 Dec; 367(3):425-432. PubMed ID: 30305427
[TBL] [Abstract][Full Text] [Related]
2. Lipocalin-type prostaglandin D synthase-derived PGD
Omori K; Morikawa T; Kunita A; Nakamura T; Aritake K; Urade Y; Fukayama M; Murata T
J Pathol; 2018 Jan; 244(1):84-96. PubMed ID: 29124765
[TBL] [Abstract][Full Text] [Related]
3. Lipocalin-type prostaglandin D synthase produces prostaglandin D2 involved in regulation of physiological sleep.
Qu WM; Huang ZL; Xu XH; Aritake K; Eguchi N; Nambu F; Narumiya S; Urade Y; Hayaishi O
Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17949-54. PubMed ID: 17093043
[TBL] [Abstract][Full Text] [Related]
4. Nrf2 is essential for the expression of lipocalin-prostaglandin D synthase induced by prostaglandin D2.
Kim KH; Sadikot RT; Xiao L; Christman JW; Freeman ML; Chan JY; Oh YK; Blackwell TS; Joo M
Free Radic Biol Med; 2013 Dec; 65():1134-1142. PubMed ID: 24029383
[TBL] [Abstract][Full Text] [Related]
5. Lipocalin-type prostaglandin D2 synthase protein regulates glial cell migration and morphology through myristoylated alanine-rich C-kinase substrate: prostaglandin D2-independent effects.
Lee S; Jang E; Kim JH; Kim JH; Lee WH; Suk K
J Biol Chem; 2012 Mar; 287(12):9414-28. PubMed ID: 22275363
[TBL] [Abstract][Full Text] [Related]
6. L-PGDS-produced PGD
Fujimori K; Aritake K; Oishi Y; Nagata N; Maehara T; Lazarus M; Urade Y
Sci Rep; 2019 Feb; 9(1):1931. PubMed ID: 30760783
[TBL] [Abstract][Full Text] [Related]
7. Role of the L-PGDS-PGD2-DP1 receptor axis in sleep regulation and neurologic outcomes.
Ahmad AS; Ottallah H; Maciel CB; Strickland M; Doré S
Sleep; 2019 Jun; 42(6):. PubMed ID: 30893431
[TBL] [Abstract][Full Text] [Related]
8. Biochemical, functional, and pharmacological characterization of AT-56, an orally active and selective inhibitor of lipocalin-type prostaglandin D synthase.
Irikura D; Aritake K; Nagata N; Maruyama T; Shimamoto S; Urade Y
J Biol Chem; 2009 Mar; 284(12):7623-30. PubMed ID: 19131342
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin D(2) is crucial for seizure suppression and postictal sleep.
Kaushik MK; Aritake K; Kamauchi S; Hayaishi O; Huang ZL; Lazarus M; Urade Y
Exp Neurol; 2014 Mar; 253():82-90. PubMed ID: 24333565
[TBL] [Abstract][Full Text] [Related]
10. [Functional analyses of lipocalin-type and hematopoietic prostaglandin D synthases].
Urade Y; Eguchi N; Aritake K; Hayaishi O
Nihon Yakurigaku Zasshi; 2004 Jan; 123(1):5-13. PubMed ID: 14695453
[TBL] [Abstract][Full Text] [Related]
11. Role of Lipocalin-Type Prostaglandin D Synthase in Experimental Osteoarthritis.
Najar M; Ouhaddi Y; Paré F; Lussier B; Urade Y; Kapoor M; Pelletier JP; Martel-Pelletier J; Benderdour M; Fahmi H
Arthritis Rheumatol; 2020 Sep; 72(9):1524-1533. PubMed ID: 32336048
[TBL] [Abstract][Full Text] [Related]
12. Endogenous prostaglandin D2 synthesis reduces an increase in plasminogen activator inhibitor-1 following interleukin stimulation in bovine endothelial cells.
Negoro H; Soo Shin W; Hakamada-Taguchi R; Eguchi N; Urade Y; Goto A; Toyo-Oka T; Fujita T; Omata M; Uehara Y
J Hypertens; 2002 Jul; 20(7):1347-54. PubMed ID: 12131531
[TBL] [Abstract][Full Text] [Related]
13. Lipocalin-prostaglandin D synthase is a critical beneficial factor in transient and permanent focal cerebral ischemia.
Saleem S; Shah ZA; Urade Y; Doré S
Neuroscience; 2009 Apr; 160(1):248-54. PubMed ID: 19254753
[TBL] [Abstract][Full Text] [Related]
14. Lipocalin-type and hematopoietic prostaglandin D synthases as a novel example of functional convergence.
Urade Y; Eguchi N
Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():375-82. PubMed ID: 12432930
[TBL] [Abstract][Full Text] [Related]
15. L-PGDS deficiency accelerated the development of naturally occurring age-related osteoarthritis.
Ouhaddi Y; Najar M; Paré F; Lussier B; Urade Y; Benderdour M; Pelletier JP; Martel-Pelletier J; Fahmi H
Aging (Albany NY); 2020 Dec; 12(24):24778-24797. PubMed ID: 33361529
[TBL] [Abstract][Full Text] [Related]
16. Lipocalin-type prostaglandin D
Kumar S; Srivastava A; Palaia T; Hall C; Lee J; Stevenson M; Zhao CL; Ragolia L
Prostaglandins Other Lipid Mediat; 2020 Aug; 149():106429. PubMed ID: 32145387
[TBL] [Abstract][Full Text] [Related]
17. Stable expression of lipocalin-type prostaglandin D synthase in cultured preadipocytes impairs adipogenesis program independently of endogenous prostanoids.
Hossain MS; Chowdhury AA; Rahman MS; Nishimura K; Jisaka M; Nagaya T; Shono F; Yokota K
Exp Cell Res; 2012 Feb; 318(4):408-15. PubMed ID: 22100987
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of lipocalin-type-prostaglandin D synthase in ulcerative colitis and exacerbating role in murine colitis.
Hokari R; Kurihara C; Nagata N; Aritake K; Okada Y; Watanabe C; Komoto S; Nakamura M; Kawaguchi A; Nagao S; Urade Y; Miura S
Am J Physiol Gastrointest Liver Physiol; 2011 Mar; 300(3):G401-8. PubMed ID: 21163901
[TBL] [Abstract][Full Text] [Related]
19. L-PGDS Attenuates Acute Lung Injury by Prostaglandin D
Horikami D; Fujii W; Aritake K; Murata T
J Immunol; 2021 Nov; 207(10):2545-2550. PubMed ID: 34615734
[TBL] [Abstract][Full Text] [Related]
20. Substrate-induced product-release mechanism of lipocalin-type prostaglandin D synthase.
Shimamoto S; Nakagawa Y; Hidaka Y; Maruno T; Kobayashi Y; Kawahara K; Yoshida T; Ohkubo T; Aritake K; Kaushik MK; Urade Y
Biochem Biophys Res Commun; 2021 Sep; 569():66-71. PubMed ID: 34237429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
